Abstract 4634: Population pharmacokinetic model of ibrutinib, a Bruton's tyrosine kinase inhibitor, for the treatment of B-cell malignancies

2014 ◽  
Author(s):  
Eleonora Marostica ◽  
Juthamas Sukbuntherng ◽  
David Loury ◽  
Jan D. Jong ◽  
Xavier Woot de Trixhie ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Population Pharmacokinetic Model ◽  
Pharmacokinetic Model ◽  
Kinase Inhibitor ◽  
Population Pharmacokinetic ◽  
Bruton’S Tyrosine Kinase ◽  
B Cell Malignancies ◽  
Bruton's Tyrosine Kinase

scholarly journals Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies

2015 ◽  
Vol 1358 (1) ◽  
pp. 82-94 ◽  
Author(s):  
Urte Gayko ◽  
Mann Fung ◽  
Fong Clow ◽  
Steven Sun ◽  
Elizabeth Faust ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Bruton’S Tyrosine Kinase ◽  
B Cell Malignancies ◽  
Bruton's Tyrosine Kinase
Sign in / Sign up

Export Citation Format

Share Document